CAF-related miR-642a-3p supports the migration, invasion, and EMT of hepatocellular carcinoma by targeting SERPINE1

Author:

Zhang Shuo1,Cao Gang2,Shen Shuijie1,Wu Yu1,Tan Xiying3,Jiang Xiaoyan1

Affiliation:

1. Nantong Hospital of Traditional Chinese Medicine

2. Nantong Maternal and Child Health Care Hospital

3. Jiangsu Province Hospital of Chinese Medicine

Abstract

Abstract Hepatocellular carcinoma (HCC) is one of the most deadly malignancies. Due to the late detection of HCC, the treatment are not satisfactory, accompanied by poor prognosis. Therefore, early detection has important value for HCC treatment. MicroRNAs (miRNAs), the intercellular communication in the tumor microenvironment, are widely accepted as molecular markers of HCC. However, there are few studies on miRNAs involved in the crosstalk between cancer-associated fibroblast (CAF) and HCC cells. In the study, transcriptome sequencing, siRNA, co-culture, reverse transcription quantitative real-time PCR (RT-qPCR), western blot, dual-luciferase reporter system, and xenograft tumor model, were used to explore the role of miR-642a-3p/SERPINE1 axis in HCC progression. The results showed that in co-culture with CAF, the expression of SERPINE1 mRNA decreased, whereas miR-642a-3p expression increased in Huh7 cells. SERPINE1 knockdown significantly enhanced the invasion ability and increased miR-642a-3p expression in Huh7 cells. Dual-luciferase reporter assay discovered that miR-642a-3p had a binding effect with SERPINE1, suggesting that SERPINE1 was a target of miR-642a-3p. In addition, miR-642a-3p mimics inhibited SERPINE1 expression and promoted the migration, invasion, and EMT of Huh7 cells, whereas miR-642a-3p inhibitor had the opposite effect. More importantly, miR-642a-3p knockdown inhibited the proliferation and spread of xenograft tumors in the liver. miR-642a-3p knockdown significantly inhibited epithelial-mesenchymal transition (EMT) in the liver. These findings reveal that the miR-642a-3p/SERPINE1 axis plays an important role in the invasion and metastasis of HCC, and can be used as a novel therapeutic target for HCC.

Publisher

Research Square Platform LLC

Reference48 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3